Hearing Loss and Dizziness in Patients Receiving Oxaliplatin for Solid Tumors

Completed

Conditions studied: Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific

In brief

RATIONALE: Understanding how oxaliplatin affects hearing loss, dizziness, and peripheral neuropathy may improve the ability to plan effective treatment for patients receiving oxaliplatin for solid tumors. PURPOSE: This clinical trial is studying hearing loss and dizziness in patients receiving oxaliplatin for solid tumors.

Key facts

Study ID

NCT00305799

Run by

Case Comprehensive Cancer Center

People needed

59

Starts

2005-11-01

Expected to finish

2014-11-01

Last updated by the study team

2014-11-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center — Cleveland, Ohio, United States
• MetroHealth Medical Center — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.